Author

T. Shapira

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. August· 1 shared A. Chin· 1 shared A. D. Olmstead· 1 shared A. Desilets· 1 shared B. Imbiakha· 1 shared B. Quon· 1 shared D. L. Sexton· 1 shared D. W. Buchholz· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. August

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The diversity of clinical Mycobacterium abscessus isolates in morphology, glycopeptidolipids and infection rates in a macrophage model

V. Pichler, L. Dalkilic, G. Shoaib, T. Shapira, L. Rankine-Wilson, Y.-M. Boudehen, J. Chao, D. L. Sexton, M. D. Prieto, B. Quon, E. I. Tocheva, L. Kremer, W. Hsiao, Y. Av-Gay

This study examines the relationship between morphology, glycopeptidolipids, and infectivity in Mycobacterium abscessus clinical isolates using macrophage models.

bioRxiv · Feb 29, 2024 · PreprintMicrobiology

A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice

T. Shapira, I. A. Monreal, S. P. Dion, M. Jager, A. Desilets, A. D. Olmstead, T. Vandal, D. W. Buchholz, B. Imbiakha, G. Gao, A. Chin, W. D. Rees, T. Steiner, I. R. Nabi, E. Marsault, , F. Jean

This paper identifies N-0385 as a potent inhibitor of TMPRSS2 that blocks SARS-CoV-2 variants and protects mice from infection and mortality.

bioRxiv · May 3, 2021 · PreprintMicrobiology